1. The SAHaRA study compared liberal and restrictive red-cell transfusion strategies in patients with aneurysmal subarachnoid hemorrhage (SAH) and anemia.
2. No significant difference in neurologic outcomes were seen at 12 months between the two strategies.
3. The trial involved 742 critically ill patients.
4. There were also no significant differences between the strategies in terms of adverse events and quality of life.

Source: The New England Journal of Medicine